MENU
component-ddb-728x90-v1-01-desktop

CDC recalls Mibelas birth control

mad-recall-3-1497053112334-7064620-ver1-0.jpg

MISSOULA, Mont. - A nationwide recall for the oral contraceptive Mibelas could affect your health.

The Centers for Disease Control and Prevention says nearly 20 percent of women use a contraceptive.

"Oral contraception is useful for different things. One, is (for) people with really difficult periods. They can use birth control pills to manage their symptoms," nurse practitioner Jodi Jeakins-Kok said. "Another use is for acne."

The company says the Mibelas recall is due to a production error that rotated the packages and placed placebo pills where hormonal pills should be -- ultimately affecting a woman's cycle.

Officials say the tablets that were taken out of sequence might place the user at risk for an unintended pregnancy.

"After 21 days you would have three days of inactive ingredients. So the risk of pregnancy in this kind of a mishap is not as troublesome as some of them would be," said pharmacist Karen Iverson.

NBC Montana reached out to Mibelas producer Lupin Pharmaceuticals. They weren't able to say which Montana distributors carry the product or how many packets were affected. They said the lot number "L600518" is the lot being recalled. Users can find on the packet.

"Women that are on Mibelas should contact their health care provider if they have any questions," said Jeakins-Kok.

She advises to use a backup method until clearing birth control issues with a doctor.

Consumers with questions regarding this recall can contact Lupin by phone at 1-800-399-2561. Adverse events or quality problems experienced by the use of Mibelas can be reported to the Federal Drug Administration's MedWatch program here.

Trending